Quantitative effects of Nf1 inactivation on in vivo hematopoiesis

Journal of Clinical Investigation

Volumn 108, Issue 5, 2001, Pages 709-715

  Zhang, Youyan ^a,b   Taylor, Brigit R ^c   Shannon, Kevin ^c   Clapp, D Wade ^a,b,d  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL MUTANT; CHIMERA; CYTOMETRY; FETUS; HEMATOPOIESIS; LEUKEMIA; LIVER CELL; MOUSE; MYELOPROLIFERATIVE DISORDER; NONHUMAN; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0034789570     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI12758     Document Type: Article

References (39)

1. The hallmarks of cancer
2. Proteins regulating Ras and its relatives
3. Neurofibromatosis type 1 and Ras-mediated signaling: Filling in the GAPs
4. The NF1 gene as a tumor suppressor
5. Juvenile myelomonocytic leukemia
6. Juvenile myelomonocyric leukemia: Molecular understanding and prospects for therapy
7. Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues
8. Tumorigenic and developmental consequences of a targeted Nf1 mutation in the mouse
9. Nf1 deficiency causes Ras-mediated granulocyte/macrophage colony stimulating factor hypersensitivity and chronic myeloid leukaemia
10. Nf1 regulates hemaropoietic progenitor cell growth and ras signaling in response to multiple cytokines
11. Nf1 and Gmcsf interact in myeloid leukemogenesis
12. Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders
13. Genetic analysis is consistent with the hypothesis that NF1 limits myeloid cell growth through p21ras
14. Loss of NF1 results in activation of tine Ras signaling pathway and leads to aberrant growth in hematopoietic cells
15. Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders
16. Genetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo
17. Hyperactivation of p21ras and the hematopoietic specific Rho GTPase, Rac2, cooperate to alter the proliferation of neurofibromin deficient mast cells in vivo and in vitro
18. Lymphoid blast crisis of B-lineage phenotype with monosomy 7 in a patient with juvenile chronic myelogenous leukemia (JCML)
19. Evidence that juvenile myelomonocytic leukemia can arise from a pluripotential stem cell
20. The regulation and function of p21ras in T cells
21. T cells: Getting a GRP on Ras
22. Loss of Fanc C function results in decreased hematopoietic stem cell repopulating ability
23. Competitive repopulation: A new assay for long-term stem cell functional capacity
24. Loss of proliferative capacity in immunohemopoietic stem cells caused by serial transplantation rather that aging
25. Myeloid malignancies induced by alkylating agents in Nf1 mice
26. Monosomy 7 myeloproliferative disease in children with neurofibromatosis, type 1: Epidemiology and molecular analysis
27. Patterns of hematopoietic lineage involvement in children with neurofibromatosis type 1 and malignant myeloid disorders
28. Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects
29. Neurofibromatosis and childhood leukemia
30. Neurofibromatosis and childhood leukaemia/lymphoma: A population-based UKCCSG study
31. Neurofibromin, the product of the NFl tumor suppressor gene, regulates the apoptotic decision of hematopoietic progenitors
32. BCR/ABL directly inhibits expression of SHIP, an SH2-containing polyinosirol-5-phosphatase involved in the regulation of hematopoiesis
33. Pten is essential For embryonic development and tumour suppression
34. Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors
35. In vivo kinetics of murine hemopoietic stem cells
36. Persistence of the 8:21 translocation in patients with acute myeloid leukemia type M2 in longterm remission
37. An intrinsic but cell-nonautonomous defect in GATA-1-overexpressing mouse erythroid cells
38. Chromosome pattern in juvenile chronic myelogenous leukemia, myelodysplastic syndrome, and acute leukemia associated with neurofibromatosis
39. Myelodysplastic and myeloproliferative disorders of childhood: A study of 167 patients